CD27 and Autoimmunity: As the population of CVIDid patients with low CTLA4 + CD27 + Tregs represented a mix of patients with pulmonary inflammation but also other organ-specific autoimmunity (data not shown), abatacept may be efficacious in other CVIDid patients as well.